Type 2 Biomarkers and Eosinophil Activation in Severe Asthma and the Impact of Mepolizumab

被引：0
|
作者：
Howarth, P. [1 ]
Quirce, S. [2 ,3 ]
Papi, A. [4 ,5 ]
Israel, E. [6 ,7 ]
Mallett, S. [8 ]
Bates, S. [9 ]
Albers, F. C. [10 ]
Kwon, N. [11 ]
机构：
[1] GSK House, Global Med Franchise, Brentford, England
[2] Hosp La Paz Inst Hlth Res IdiPAZ, Dept Allergy, Madrid, Spain
[3] Inst Carlos III, CIBERES, Madrid, Spain
[4] Univ Ferrara, Dept Med Sci, Ferrara, Italy
[5] S Anna Univ Hosp, Ferrara, Italy
[6] Harvard Med Sch, Boston, MA 02115 USA
[7] Brigham & Womens Hosp, Asthma Res Ctr, 75 Francis St, Boston, MA 02115 USA
[8] GSK, Biostat, Stockley Pk, Uxbridge, Middx, England
[9] GSK, Resp Discovery Med, Stevenage, Herts, England
[10] GSK, Resp Med Franchise, Res Triangle Pk, NC USA
[11] GSK, Resp Med Franchise, London, England
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2019年 / 199卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1275
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Asthma Control In Patients With Severe Eosinophilic Asthma Treated With Mepolizumab
    Llanos-Ackert, J. -P.
    Price, R. G.
    Forshag, M.
    Yancey, S.
    Liu, M. C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [42] Evolution of patients with severe asthma treated with mepolizumab
    Martinez Mesa, Alvaro
    Cabrera Cesar, Eva
    Aguilar Galvez, Ana
    Reina Marfil, Nuria
    Sanchez Alvarez, Esther
    Fernandez Aguirre, Maria Carmen
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [43] Mepolizumab treatment In Severe Asthma: A Case Series
    Subramani, M. Venkata
    Saygin, D.
    McCarroll, S.
    Micklewright, S.
    Ibrahim, L.
    Taliercio, R. M.
    Erzurum, S. C.
    Khatri, S. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [44] Use of Mepolizumab in the Treatment of Severe Eosinophilic Asthma
    Strauss, R. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [45] Mepolizumab is a new therapeutiv option in severe asthma
    Taube, Christian
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2014, 139 (47) : 2380 - 2380
  • [46] THE EFFECT OF MEPOLIZUMAB TREATMENT IN PATIENTS WITH SEVERE ASTHMA
    Sandhu, Yuuki
    Harada, Norihiro
    Matsuno, Kei
    Harada, Sonoko
    Sasano, Hitoshi
    Tanabe, Yuki
    Nakamura, Ai
    Takeshige, Tomohito
    Ishimori, Ayako
    Katsura, Yoko
    Makino, Fumihiko
    Ito, Jun
    Atsuta, Ryo
    Akiba, Hisaya
    Takahashi, Kazuhisa
    RESPIROLOGY, 2017, 22 : 98 - 99
  • [47] Mepolizumab, quality of life, and severe eosinophilic asthma
    Pavord, Ian D.
    LANCET RESPIRATORY MEDICINE, 2017, 5 (05): : 362 - 363
  • [48] Mepolizumab for eosinophilic severe asthma: recent studies
    Robinson, Douglas S.
    Kariyawasam, Harsha H.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (06) : 909 - 914
  • [49] Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
    Ortega, Hector G.
    Liu, Mark C.
    Pavord, Ian D.
    Brusselle, Guy G.
    FitzGerald, J. Mark
    Chetta, Alfredo
    Humbert, Marc
    Katz, Lynn E.
    Keene, Oliver N.
    Yancey, Steven W.
    Chanez, Pascal
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (13): : 1198 - 1207
  • [50] Exacerbations of severe asthma in patients treated with mepolizumab
    Shrimanker, Rahul
    Pavord, Ian D.
    Yancey, Steve
    Heaney, Liam G.
    Green, Ruth H.
    Bradding, Peter
    Hargadon, Beverley
    Brightling, Chris E.
    Wardlaw, Andrew J.
    Haldar, Pranabashis
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52 (06)
12345